Related references
Note: Only part of the references are listed.CCL2/CCR2 signaling in cancer pathogenesis
Qiongyu Hao et al.
CELL COMMUNICATION AND SIGNALING (2020)
The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
Denisa Baci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome Analysis
Kuo-Min Su et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors: Current Status and Perspectives
Yu Sun et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Mucinous borderline ovarian tumors withBRAF(V600E)mutation may have low risk for progression to invasive carcinomas
Kaori Ohnishi et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2020)
Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance
Milad Ashrafizadeh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CTL Attenuation Regulated by PS1 in Cancer-Associated Fibroblast
Hongyu Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Immunohistochemical Analysis of PGC-1α and ERRα Expression Reveals Their Clinical Significance in Human Ovarian Cancer
Xiqi Huang et al.
ONCOTARGETS AND THERAPY (2020)
Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk
Andrea Tumminia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
Nele Loret et al.
CANCERS (2019)
Epithelial-mesenchymal transition in serous and mucinous epithelial tumors of the ovary
Geet Bhuyan et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)
Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma
Chia-Ming Chang et al.
ONCOTARGET (2018)
Immunogenomic Analyses of Advanced Serous Ovarian Cancer Reveal Immune Score is a Strong Prognostic Factor and an Indicator of Chemosensitivity
Dapeng Hao et al.
CLINICAL CANCER RESEARCH (2018)
GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells
Hsiang-Ju Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers
Pawel Sadlecki et al.
TUMOR BIOLOGY (2018)
PGC1 alpha: Friend or Foe in Cancer?
Francesca Mastropasqua et al.
GENES (2018)
Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer
Yuan Xu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary
Ahmed El-Balat et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Epigenetics in ovarian cancer: premise, properties, and perspectives
Qilian Yang et al.
MOLECULAR CANCER (2018)
Cancer of the ovary, fallopian tube, and peritoneum
Jonathan S. Berek et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome Analysis
Cheng-Chang Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
Landon Browning et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The Role of Interleukin-1 in the Pathogenesis of Cancer and its Potential as a Therapeutic Target in Clinical Practice
Adi Litmanovich et al.
ONCOLOGY AND THERAPY (2018)
Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria
Steffen Hauptmann et al.
VIRCHOWS ARCHIV (2017)
Proliferation and maturation of intratumoral blood vessels in women with malignant ovarian tumors assessed with cancer stem cells marker nestin and platelet derived growth factor PDGF-B
Sylwia Czekierdowska et al.
GINEKOLOGIA POLSKA (2017)
CCR2 blockade alters the tumor microenvironment immune infiltrate and enhances anti-tumor activity in ovarian cancer
P. S. Binder et al.
GYNECOLOGIC ONCOLOGY (2017)
Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis
Chia-Ming Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Non-canonical Hedgehog signaling activation in ovarian borderline tumors and ovarian carcinomas
Petar Ozretic et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways
Nour M. El-Etreby et al.
JOURNAL OF OVARIAN RESEARCH (2017)
Immune Cell Population in Ovarian Tumor Microenvironment
Dong Li Cai et al.
JOURNAL OF CANCER (2017)
Management of Borderline Ovarian Tumors-Still a Gray Zone
Nidhi Nayyar et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2017)
Borderline tumors of the ovary: A clinicopathological study
Samia Yasmeen et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2017)
The molecular pathology of ovarian serous borderline tumors
A. Malpica et al.
ANNALS OF ONCOLOGY (2016)
Management of borderline ovarian tumors
A. du Bois et al.
ANNALS OF ONCOLOGY (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
The Evaluation of Risk Factors Associated With Relapse and Recurrence of Borderline Ovarian Tumors With Long-Term Follow-up
Piotr Sobiczewski et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy
Huimin Bai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Prediction of key genes in ovarian cancer treated with decitabine based on network strategy
Yu-Zhen Wang et al.
ONCOLOGY REPORTS (2016)
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
Jane Antony et al.
SCIENCE SIGNALING (2016)
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
Jane Antony et al.
SCIENCE SIGNALING (2016)
Targeting Src in endometriosis-associated ovarian cancer
R. Manek et al.
ONCOGENESIS (2016)
Gene Set-Based Integrative Analysis Revealing Two Distinct Functional Regulation Patterns in Four Common Subtypes of Epithelial Ovarian Cancer
Chia-Ming Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Gene Set-Based Functionome Analysis of Pathogenesis in Epithelial Ovarian Serous Carcinoma and the Molecular Features in Different FIGO Stages
Chia-Ming Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms
Robertson Mackenzie et al.
BMC CANCER (2015)
Conservative surgery in ovarian borderline tumours: A meta-analysis with emphasis on recurrence risk
Ines Vasconcelos et al.
EUROPEAN JOURNAL OF CANCER (2015)
Expression of Adiponectin and Its Receptors Is Altered in Epithelial Ovarian Tumors and Ascites-Derived Ovarian Cancer Cell Lines
Anupama Tiwari et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
Controversies in borderline ovarian tumors
Seok Ju Seong et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers
Bo-Rim Yi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Borderline epithelial tumors of the ovary: Experience of 55 patients
Vera Loizzi et al.
ONCOLOGY LETTERS (2015)
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study
F. Trillsch et al.
ANNALS OF ONCOLOGY (2014)
Immunohistochemical visualization of pro-inflammatory cytokines and enzymes in ovarian tumors
Danuta Plewka et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2014)
Bevacizumab Shows Activity in Patients With Low-Grade Serous Ovarian and Primary Peritoneal Cancer
Rachel N. Grisham et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors)
Philipp Harter et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Expression of Mitochondrial Regulators PGC1α and TFAM as Putative Markers of Subtype and Chemoresistance in Epithelial Ovarian Carcinoma
Marike Gabrielson et al.
PLOS ONE (2014)
Recent Concepts of Ovarian Carcinogenesis: Type I and Type II
Masafumi Koshiyama et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Value of GATA3 Immunostaining in Tumor Diagnosis: A Review
Nelson G. Ordonez
ADVANCES IN ANATOMIC PATHOLOGY (2013)
An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response
Patrizia Pinciroli et al.
BMC GENOMICS (2013)
Tyrosine Sulfation of Chemokine Receptor CCR2 Enhances Interactions with Both Monomeric and Dimeric Forms of the Chemokine Monocyte Chemoattractant Protein-1 (MCP-1)
Joshua H. Y. Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Histologic distribution of borderline ovarian tumors worldwide: a systematic review
Taejong Song et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2013)
Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes
Katherine Stemke-Hale et al.
MODERN PATHOLOGY (2013)
Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor
Margarita Romeo et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis
Loukia N. Lili et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer
Michelle Buehler et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Interleukin-1β Promotes Ovarian Tumorigenesis through a p53/NF-κB-Mediated Inflammatory Response in Stromal Fibroblasts
Isaiah Gregory Schauer et al.
NEOPLASIA (2013)
TGF-Beta Induces Serous Borderline Ovarian Tumor Cell Invasion by Activating EMT but Triggers Apoptosis in Low-Grade Serous Ovarian Carcinoma Cells
Jung-Chien Cheng et al.
PLOS ONE (2012)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
F. E. van Leeuwen et al.
HUMAN REPRODUCTION (2011)
Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin
J-C Cheng et al.
ONCOGENE (2011)
Current Update on Borderline Ovarian Neoplasms
Neeraj Lalwani et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Clinical management of borderline ovarian tumors
F. Trillsch et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Identifying Tightly Regulated and Variably Expressed Networks by Differential Rank Conservation (DIRAC)
James A. Eddy et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
Jessica N. McAlpine et al.
BMC CANCER (2009)
Expression of Na,K-ATPase-β1 subunit increases uptake and sensitizes carcinoma cells to oxaliplatin
Ramakumar Tummala et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression
Junko Yoshida et al.
MEDICAL MOLECULAR MORPHOLOGY (2009)
Expression and prognostic significance of SIRT1 in ovarian epithelial tumours
Kyu Yun Jang et al.
PATHOLOGY (2009)
Endogenous Interleukin-4 Promotes Tumor Development by increasing Tumor Cell Resistance to Apoptosis
Zhiguang Li et al.
CANCER RESEARCH (2008)
Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors
Michael S. Anglesio et al.
MOLECULAR CANCER RESEARCH (2008)
PGC-1α induces apoptosis in human epithelial ovarian cancer cells through a PPARγ-dependent pathway
Yan Zhang et al.
CELL RESEARCH (2007)
Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients
S. Hosono et al.
BRITISH JOURNAL OF CANCER (2007)
KRAS and BRAF mutations in ovarian tumors:: A comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants
Doris Mayr et al.
GYNECOLOGIC ONCOLOGY (2006)
Borderline ovarian tumors: Current concepts for prognostic factors and clinical management
Monica Brown Jones
CLINICAL OBSTETRICS AND GYNECOLOGY (2006)
Pathophysiology of impaired ovarian function in galactosaemia
T. Forges et al.
HUMAN REPRODUCTION UPDATE (2006)
The epithelial-mesenchymal transition: new insights in signaling, development, and disease
JM Lee et al.
JOURNAL OF CELL BIOLOGY (2006)
Pathophysiology of impaired ovarian function in galactosaemia
T. Forges et al.
HUMAN REPRODUCTION UPDATE (2006)
Molecular pathogenesis of ovarian borderline tumors: New insights and old challenges
IM Shih et al.
CLINICAL CANCER RESEARCH (2005)
Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors
NLG Sieben et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Milk/dairy products consumption, galactose metabolism and ovarian cancer: meta-analysis of epidemiological studies
LQ Qin et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2005)
Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'
E Charafe-Jaufrret et al.
JOURNAL OF PATHOLOGY (2004)
Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors
CL Ho et al.
CANCER RESEARCH (2004)
Borderline ovarian tumors: Key points and workshop summary
SG Silverberg et al.
HUMAN PATHOLOGY (2004)
Long-term survival and patterns of care in women with ovarian tumors of low malignant potential
CL Trimble et al.
GYNECOLOGIC ONCOLOGY (2002)
Risk factors for epithelial borderline ovarian tumors: Results of a Swedish case-control study
T Riman et al.
GYNECOLOGIC ONCOLOGY (2001)
Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: A prospective study
G Zanetta et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Na,K-ATPase β-subunit is required for epithelial polarization, suppression of invasion, and cell motility
SA Rajasekaran et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Role of Src expression and activation in human cancer
RB Irby et al.
ONCOGENE (2000)
Share Paper
